Effects of modified Shu-Gan-Liang-Xue decoction combined with anastrozole on osteoblastic proliferation and differentiation of MC3T3-E1 cells

Aromatase inhibitors (AIs) are widely used in the treatment of hormone-dependent breast cancer and as a result, aromatase inhibitor-associated bone loss (AIBL) has become a major concern amongst patients receiving AI treatment. Modified Shu-Gan-Liang-Xue decoction (mSGLXD), a clinical prescription,...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHOU, FEI, HAN, SHUYAN, ZHOU, NING, ZHENG, WENXIAN, LI, PINGPING
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270318/
https://www.ncbi.nlm.nih.gov/pubmed/25405542
http://dx.doi.org/10.3892/mmr.2014.2962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270318/
https://www.ncbi.nlm.nih.gov/pubmed/25405542
http://dx.doi.org/10.3892/mmr.2014.2962

Ejemplares similares